Pharmaceutical Supply Chain Management Blockchain - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512243487

Publication Date:

December 6, 2024

Pages:

117

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Pharmaceutical Supply Chain Management Blockchain was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Supply Chain Management Blockchain, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Supply Chain Management Blockchain by region & country, by Type, and by Application.
The Pharmaceutical Supply Chain Management Blockchain market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Supply Chain Management Blockchain.
麻豆原创 Segmentation
By Company
Amazon Web Services
Chronicled
Doc.AI
Embleema
Factom Protocol
FarmaTrust
Guardtime Federal
Hashed Health
Huawei
IBM
Medicalchain
Microsoft
SAP
Segment by Type:
Private Blockchain
Public Blockchain
Consortium Blockchain
Segment by Application
Drug Development and Clinical Trials
Logistics and Warehousing Management
Drug Authenticity Verification
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Supply Chain Management Blockchain manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Supply Chain Management Blockchain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Supply Chain Management Blockchain in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Pharmaceutical Supply Chain Management Blockchain Product Introduction
1.2 Global Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Size Forecast
1.3 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Trends & Drivers
1.3.1 Pharmaceutical Supply Chain Management Blockchain Industry Trends
1.3.2 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Drivers & Opportunity
1.3.3 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Challenges
1.3.4 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Supply Chain Management Blockchain Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Supply Chain Management Blockchain Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical Supply Chain Management Blockchain Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Supply Chain Management Blockchain Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Supply Chain Management Blockchain
2.6 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Competitive Analysis
2.6.1 Pharmaceutical Supply Chain Management Blockchain 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Supply Chain Management Blockchain Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Supply Chain Management Blockchain as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Private Blockchain
3.1.2 Public Blockchain
3.1.3 Consortium Blockchain
3.2 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Type
3.2.1 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Supply Chain Management Blockchain Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Supply Chain Management Blockchain Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Development and Clinical Trials
4.1.2 Logistics and Warehousing Management
4.1.3 Drug Authenticity Verification
4.1.4 Others
4.2 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Application
4.2.1 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Supply Chain Management Blockchain Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Supply Chain Management Blockchain Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Region
5.1.1 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Supply Chain Management Blockchain Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
5.2.2 North America Pharmaceutical Supply Chain Management Blockchain Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical Supply Chain Management Blockchain Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical Supply Chain Management Blockchain Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
5.5.2 South America Pharmaceutical Supply Chain Management Blockchain Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical Supply Chain Management Blockchain Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Supply Chain Management Blockchain Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Supply Chain Management Blockchain Sales Value
6.3 United States
6.3.1 United States Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.5.2 China Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Supply Chain Management Blockchain Sales Value, 2019-2030
6.9.2 India Pharmaceutical Supply Chain Management Blockchain Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Supply Chain Management Blockchain Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amazon Web Services
7.1.1 Amazon Web Services Profile
7.1.2 Amazon Web Services Main Business
7.1.3 Amazon Web Services Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.1.4 Amazon Web Services Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.1.5 Amazon Web Services Recent Developments
7.2 Chronicled
7.2.1 Chronicled Profile
7.2.2 Chronicled Main Business
7.2.3 Chronicled Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.2.4 Chronicled Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.2.5 Chronicled Recent Developments
7.3 Doc.AI
7.3.1 Doc.AI Profile
7.3.2 Doc.AI Main Business
7.3.3 Doc.AI Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.3.4 Doc.AI Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.3.5 Embleema Recent Developments
7.4 Embleema
7.4.1 Embleema Profile
7.4.2 Embleema Main Business
7.4.3 Embleema Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.4.4 Embleema Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.4.5 Embleema Recent Developments
7.5 Factom Protocol
7.5.1 Factom Protocol Profile
7.5.2 Factom Protocol Main Business
7.5.3 Factom Protocol Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.5.4 Factom Protocol Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.5.5 Factom Protocol Recent Developments
7.6 FarmaTrust
7.6.1 FarmaTrust Profile
7.6.2 FarmaTrust Main Business
7.6.3 FarmaTrust Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.6.4 FarmaTrust Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.6.5 FarmaTrust Recent Developments
7.7 Guardtime Federal
7.7.1 Guardtime Federal Profile
7.7.2 Guardtime Federal Main Business
7.7.3 Guardtime Federal Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.7.4 Guardtime Federal Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.7.5 Guardtime Federal Recent Developments
7.8 Hashed Health
7.8.1 Hashed Health Profile
7.8.2 Hashed Health Main Business
7.8.3 Hashed Health Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.8.4 Hashed Health Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.8.5 Hashed Health Recent Developments
7.9 Huawei
7.9.1 Huawei Profile
7.9.2 Huawei Main Business
7.9.3 Huawei Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.9.4 Huawei Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.9.5 Huawei Recent Developments
7.10 IBM
7.10.1 IBM Profile
7.10.2 IBM Main Business
7.10.3 IBM Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.10.4 IBM Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.10.5 IBM Recent Developments
7.11 Medicalchain
7.11.1 Medicalchain Profile
7.11.2 Medicalchain Main Business
7.11.3 Medicalchain Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.11.4 Medicalchain Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.11.5 Medicalchain Recent Developments
7.12 Microsoft
7.12.1 Microsoft Profile
7.12.2 Microsoft Main Business
7.12.3 Microsoft Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.12.4 Microsoft Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.12.5 Microsoft Recent Developments
7.13 SAP
7.13.1 SAP Profile
7.13.2 SAP Main Business
7.13.3 SAP Pharmaceutical Supply Chain Management Blockchain Products, Services and Solutions
7.13.4 SAP Pharmaceutical Supply Chain Management Blockchain Revenue (US$ Million) & (2019-2024)
7.13.5 SAP Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Supply Chain Management Blockchain Industrial Chain
8.2 Pharmaceutical Supply Chain Management Blockchain Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Supply Chain Management Blockchain Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Supply Chain Management Blockchain Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Amazon Web Services
Chronicled
Doc.AI
Embleema
Factom Protocol
FarmaTrust
Guardtime Federal
Hashed Health
Huawei
IBM
Medicalchain
Microsoft
SAP

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.